Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Extranodal NK-T-Cell × avelumab × 90 days × Clear all

Sponsor

Conditions

Carcinoma, Transitional Cell 10 Urinary Bladder Neoplasms 9 Carcinoma, Merkel Cell 8 Breast Neoplasms 5 Neoplasm Metastasis 4 Carcinoma, Renal Cell 4 Urethral Neoplasms 3 Ureteral Neoplasms 3 Skin Neoplasms 3 Melanoma 3 Triple Negative Breast Neoplasms 2 Ovarian Neoplasms 2 Neuroendocrine Tumors 2 Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Uveal Melanoma 1 Thymoma 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Prostatic Neoplasms 1 Primary Myelofibrosis 1 Peritoneal Neoplasms 1 Penile Squamous Cell Carcinoma (PSCC) 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Osteosarcoma 1 Neoplasm, Residual 1 Motor Activity 1 Metastatic Urothelial Cancer 1 Mesothelioma 1

Interventions

pegaspargase 4 tislelizumab 1 sugemalimab 1 relatlimab 1 pembrolizumab 1 fludarabine phosphate 1 fludarabine 1 Whole-Body Irradiation 1 Vorinostat 1 Valganciclovir 1 Transplantation 1 Therapeutics 1 Tacrolimus 1 Radiotherapy 1 Polymerase Chain Reaction 1 Peripheral Blood Stem Cell Transplantation 1 Oxaliplatin 1 Nivolumab 1 Mycophenolic Acid 1 Methylprednisolone 1 Immune Checkpoint Inhibitors 1 Gemcitabine 1 Ganciclovir 1 Foscarnet 1 Flow Cytometry 1 Etoposide 1 Cyclophosphamide 1 Busulfan 1 Azacitidine 1 Asparaginase 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡